CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4,430 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02734199
NCT02734199N/ACompleted

Highly Effective Reversible Contraceptive Initiative-Salt Lake (HER-SL)

University of Utah·observational·Posted Apr 12, 2016·Updated Apr 28, 2021

In Brief

An observational study for Birth Control and Contraception. Completed, enrolled 4,430 participants across 1 site.

Detailed Summary

This study aims to understand the long-term health, social, and economic impacts of transitioning a community to Highly Effective Reversible Contraception (HER-C).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 12, 2016
Enrollment StartNov 1, 2014
Primary CompletionMar 1, 2020
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 10.2 years ago